Effects of calcium channel activators on contractile behavior in vascular smooth muscle.
Squibb Institute, Pharmacology Department, Princeton, NJ 08543.
S
S
Moreland
R S
RS
Moreland
D001498:3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester / Q000494:pharmacology*; D000818:Animals; D015220:Calcium Channels / Q000187:drug effects / Q000502:physiology*; D016232:Endothelins; D066298:In Vitro Techniques; D009119:Muscle Contraction / Q000187:drug effects*; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000502:physiology*; D009219:Myosin-Light-Chain Kinase / Q000378:metabolism; D010455:Peptides / Q000494:pharmacology*; D011188:Potassium / Q000494:pharmacology*; D013552:Swine
D015220:Calcium Channels; D016232:Endothelins; D010455:Peptides; D001498:3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; D009219:Myosin-Light-Chain Kinase; D011188:Potassium